Measures of Obesity and Co-Morbid Conditions in Maori

Completed

• Conditions: Body Composition

• Registration Number: NCT00208598
• Lead Sponsor: Edgar National Centre for Diabetes Research

Brief Summary

It has been proposed that a higher cut off for BMI (body mass index) is to be used in Maori to define overweight and obesity. However, no one has assessed the prevalence of co-morbid conditions associated with BMI. It is well known that Maori are at greater risk of diabetes and cardiovascular disease compared to non-Maori and a delay in the identification of those who are overweight and obese may be detrimental for Maori. We will assess BMI, other measures of adiposity and prevalence of co-morbid conditions with a comparison with a similar matched non-Maori population.

Detailed Description

This is a body composition analysis study of people self-identifying Maori and non-Maori participants from both Dunedin and Invercargill. The study consists of a clinical visit for anthropometry and oral glucose tolerance test (OGTT), followed by a single Dexa Scan visit. Participants meeting all the inclusion criteria were invited to participate in the study.

Outcome will be determined by examining Dexa Scan data and surrogate clinical endpoints. The clinical endpoints include: anthropometric measurements, Dexa analysis, bioelectric impedance, and BP measurements, and the biochemical measures of: lipid profile, fasting insulin and glucose, liver functions and uric acid levels.

Study Timeline

• Study Start: 2003-01
• Status Verified: 2005-09
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Last Update Submitted: 2005-09-13
• Study First Posted: 2005-09-21
• Last Update Posted: 2005-09-21
• Study Completion: 2005-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

• Self identify as Maori and non-Maori aged between 18-68 years
• Male and female
• Non-diabetic
• Resident of Dunedin and Invercargill

Exclusion Criteria

• The presence of diabetes, renal or liver failure, or any other medical condition which is unstable and for which they are currently having active treatment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Edgar National Centre for Diabetes Research; 🇳🇿 Dunedin, Otago, New Zealand